Steady glucose-monitor use helps blood-sugar control
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
Successful bone regeneration using stem cells derived from fatty tissue
On Nov. 5, 2025, an Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s…
‘Mind-captioning’ AI decodes brain activity to turn thoughts into text
On Nov. 5, 2025, researchers announced that reading a person’s mind using a recording of their brain activity…
MIT researchers invent new human brain model to enable disease research, drug discovery
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
WHO Reports Rift Valley fever in Mauritania and Senegal
On Nov. 5, 2025, the World Health Organization (WHO) reported that between 20 September and 30 October 2025,…
Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning
On Nov. 4, 2025, Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and…
Biotechnology | Diagnostics | Environmental | Forestry | Genomics | Marine Science | Non-Profit Research
Once thought a fantasy, effort to sequence DNA of millions of species gains momentum
On Nov. 4, 2025, six years ago this month, scientists launched a massively ambitious effort to sequence the…
Biotechnology | Disease | FDA | Therapeutics
FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
Wildfire smoke tied to higher risk of preterm birth
On Nov. 4, 2025, a team of scientists led by the University of Washington announced findings published this…
United Therapeutics Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
On Nov. 3, 2025, United Therapeutics, a public benefit corporation, announced the first clinical xenotransplantation in its EXPAND…
Scientists Replicate Pigment Behind Octopus Camouflage
On Nov. 3, 2025, scientists at the University of California, San Diego (UC San Diego) announced they have…
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
On Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
Genetic variant increases risk of heart muscle disease common in individuals of African ancestry
On Oct. 31, 2025, investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and VA…
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
VCU researchers find explosive rise in tick-linked meat allergy across the U.S.
On Oct. 30, 2025, researchers at Virginia Commonwealth University and VCU Health announced preliminary study findings that show…
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
Artificial Intelligence | Biotechnology | Chemistry | Energy | Genomics | Infectious Disease | Medical Device | Neurology | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Leiden Report Show Universities in China Dominate Top Ten Rankings
On Oct. 29, 2025, the CWTS Leiden ranking show that Harvard University dropped to third place in the…
Lilly announces $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the U.S.
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
Rice launches Brain Institute to accelerate discoveries in brain science and health
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
FDA to Accelerate Biosimilar Development and Lower costs
On Oct. 29, 2025, the U.S. Food and Drug Administration (FDA) announced it is aiming to reduce the…
Lilly partners with Nvidia on AI supercomputer to speed up drug development
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
Louisiana officials waited months to warn public of whooping cough outbreak
On Oct. 28, 2025, The Louisiana Illuminator reported that when there’s an outbreak of a vaccine-preventable disease, state…
Artificial Intelligence | Biotechnology | Clinical Research | Diagnostics | Disease | Medical Device | Therapeutics
AI-powered diabetes prevention program shows similar benefits to those led by people
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy Data
On Oct. 27, 2025, Qureator announced a major milestone, confirming a fundamental shift in drug development under the…
New Hampshire Man resumes dialysis after living with a gene-edited pig kidney for a record 271 days
On Oct. 27, 2025, a New Hampshire man resumed dialysis after living with a gene-edited pig kidney for…
Rebalancing the Gut: How AI Solved a 25-Year Crohn’s Disease Mystery
On Oct. 27, 2025, researchers at University of California San Diego School of Medicine (UC San Diego) have…
Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
Study suggests two unsuspected pathogens struck Napoleon’s army during the retreat from Russia in 1812
On Oct. 24, 2025, scientists from the Institut Pasteur announced they have genetically analyzed the remains of former…
Lilly to Acquire Adverum Biotechnologies for $12.47 per Share
On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…